In a landmark decision that will reshape how we approach obesity treatment worldwide, the World Health Organization1 has released its first-ever clinical guidelines recommending GLP-1 therapies for adults living with obesity. This isn’t merely another drug approval or incremental policy update; it represents a transformation in how the world’s leading health authority understands and addresses a condition affecting over 1 billion people globally.
Similar Posts
FTC erects additional administrative barriers to hospital mergers – Healthcare Economist
Last week, the Federal Trade Commission (FTC) increased their required premerger reporting requirements for any healthcare…
The Role Of Financial Institutions In Supporting Healthcare Business Healthsoothe
Financial institutions may not seem a likely tangent when you think about discussing healthcare, but it…
These 3 Zodiac Signs Are In For Big Financial Gains This August
Hope you’re ready to level up in your career, Libra, because this month you’re getting some…
This $99 Smart Scale Is The Closest Thing I’ve Found To An At-Home DEXA Scan
It’s easy to have a love-hate relationship with scales. Throughout my life, I’ve tried to put…
Does Melatonin Help With Anxiety?
If you are habitual of getting up in the middle of every night then there is…
Jenna Fischer Announced She Was Diagnosed With Breast Cancer Last Year—but She’s Now Cancer-Free
Jenna Fischer, best known for playing Pam Beesly in the hit TV series The Office, posted…
